Generative AI can now produce mortgage documents, such as payslips, bank statements and tax returns, that pass standard verification checks.

Mueller Water Products looks reasonably priced for the quality of the business, as strong margins support the valuation. Read more on MWA stock here.

Adobe Inc. stock gets a double upgrade to Buy after a 27% drop. Click for this ADBE update and see why I am bullish on the shares.

Ryan Joyce joins Owen for an S&P Global (SPGI) deep dive on ratings, indices, AI disruption, valuation and the stock’s moat.

CBOE seeks to list binary options on certain issuers' corporate metrics

On July 8, Mike Akins, ETF Action founding partner, joined 'Halftime Report' to discuss growth trades that remain underappreciated in comparison to the AI and semiconductor sectors that dominated the...

The Walt Disney Company stock remains a Buy due to strong free cash flow, improving streaming profits, and park/sports momentum. Click here for this DIS update.

IIPR.PR.A analysis: how IIPR managed a $290M maturity, kept a strong balance sheet, and why its 9%+ yield looks compelling. Click to read in detail now.

Apple stayed true to itself in the AI race, and Wall Street is finally rewarding the stock for it.

Everybody above the fab is a tenant I was about to message my uncle to ask if he could help me buy a PS5. What stopped me was the price. The console is more expensive now than when I first wanted …

Ryder System has delivered strong performance, up 50% in a year, driven by business transformation and robust free cash flow. Click to read more on R stock.

CFRA highlights standout ETFs in memory chips, space exploration and securitized debt that gathered billions in assets

Investors are also celebrating Meta's launch Thursday of Muse Spark 1.1.

Cue Biopharma (CUE) stock analysis: overvaluation, cash runway risk, and likely dilution could triple shares.

NovoCure Limited downgrade after TRIDENT OS miss; growth catalysts, raised 2026 guidance, and key risks ahead. Click for this NVCR update.

iShares Russell 1000 ETF outlook: tech concentration, rising rates, and inflation risks pressure returns. Click to read more on IWB

Chewy remains a 'Buy' despite a ~40% YTD decline and a guidance cut. Here's what investors need to know about CHWY stock.

Uranium Royalty Corp. is reiterated as a Buy below $4, capitalizing on rising uranium demand and prices. Read more on UROY stock here.

RUSTON, La., July 10, 2026 (GLOBE NEWSWIRE) -- Origin Bancorp, Inc. (NYSE: OBK) ('Origin”), the financial holding company for Origin Bank, plans to issue second quarter 2026 results after the market closes on Wednesday, July 22, 2026, and hold a conference call to discuss such results on Thursday, July 23, 2026, at 8:00 a.m. Central Time (9:00 a.m. Eastern Time). The conference call will be hosted by Drake Mills, Chairman, President and CEO of Origin, William J. Wallace, IV, Chief Financial Officer of Origin, and Lance Hall, President and CEO of Origin Bank.

Elkem ASA (ELKEF) Q2 2026 Earnings Call July 10, 2026 3:00 AM EDTCompany ParticipantsOdd-Geir Lyngstad - Vice President of Finance & Investor...

JPMorgan Chase & Co. found that eight agents beat both the traditional 60/40 portfolio and the bank’s own rules-based market regime model.

You may be concerned about the recent declines in AI stocks such as NVDA.

Jim Cramer is making a bold call that the AI race already has a winner, and his reasoning has nothing to do with which model is smartest. It has everything to do with a deal already hiding in plain sight across 2.5 billion devices.

Delta Air Lines, Inc. (DAL) Q2 2026 Earnings Call July 10, 2026 10:00 AM EDTCompany ParticipantsJulie Stewart - Vice President of Investor Relations &...

The real signal lay beyond the headline numbers, in a problem management kept admitting to: they simply couldn't keep up with demand.

As finance technology grows more decentralized, corporate finance teams are realizing the real enterprise product is the control layer.

Phillips 66 (PSX) stock dips after a 6-day rally, yet earns Strong Buy ratings. See analyst targets, risks, and why volatility may offer entry points.

Wall Street lifts obesity drug targets for Eli Lilly and AbbVie as a new Medicare GLP-1 Bridge program expands access to Zepbound and Lilly's oral pill Foundayo.

Stepan Company remains a Buy due to attractive valuation, despite recent underperformance versus the S&P 500. Read more on SCL stock here.

Jim Cramer is furious that investors keep dumping one of the most proprietary chip companies ever built while rewarding a commodity memory stock with a higher forward multiple. The numbers behind his argument are harder to dismiss than you might expect.

CEBU CITY — SM Prime Holdings Inc. wants to undertake more large-scale integrated developments across the country following the opening of a new arena at SM Seaside City Cebu, with senior executive Hans Sy saying the company remained on the lookout for similar opportunities.

The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET.

NEW YORK, July 10, 2026 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock and warrants of CERo Therapeutics Holdings, Inc. CERo Therapeutics Holdings, Inc.’s securities were suspended on October 31, 2025 and have not traded on Nasdaq since that time.

Beta is one of several electric air taxi makers racing to secure Federal Aviation Administration certification and start flying passengers commercially.

Tesla just posted its biggest Q2 delivery number ever, but the stock dropped sharply anyway, and the real question investors are now asking has nothing to do with cars.

South Korean chipmaker SK hynix raised $26.5 billion in its U.S. market debut, completing the largest-ever U.S. listing by a foreign company.

Delta Air Lines (NYSE:DAL) reported record June-quarter revenue and better-than-expected profitability, with executives telling analysts that strong demand, fare momentum and diversified revenue streams are supporting the carrier’s full-year outlook despite a sharp increase in fuel costs. Chief Exe

Viking Therapeutics remains attractive, advancing its GLP-1 weight-loss pipeline, with Phase 3 trials progressing. Read more on VKTX stock here.

Tesla, Inc.'s Q2 delivery surge, FSD and energy growth: learn why estimates may be beaten, yet valuation is rich. Click for this TSLA update.

InterDigital is rated Hold, recent sell-off reflects fair value tension between strong fundamentals and an expensive entry point. Read more on IDCC stock here.